Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway-Reference-Cited by-同舟云学术

Elevated estrogen receptor β expression in triple negative breast cancer cells is associated with sensitivity to doxorubicin by inhibiting the PI3K/AKT/mTOR signaling pathway

Published:2020-05-28 Issue:2 Volume:20 Page:1630-1636
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Lei Shanshan¹,Fan Peizhi²,Wang Mengchuan¹,Zhang Chaojie²,Jiang Yu³,Huang Shulin²,Fang Meng²,He Zili⁴,Wu Aiguo¹

Affiliation:

1. Department of General Surgery, Zhujiang Hospital (The Second School of Clinical Medicine), Southern Medical University, Guangzhou, Guangdong 510282, P.R. China

2. Department of Breast and Thyroid Surgery, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan 410005, P.R. China

3. Hunan Provincial Key Laboratory of Emergency and Critical Care Metabonomics, Institute of Emergency Medicine, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan 410005, P.R. China

4. Laboratory of Hepatobiliary Molecular Oncology, Department of Hepatobiliary Surgery, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, Hunan 410005, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polygonatum sibiricum component liquiritigenin restrains breast cancer cell invasion and migration by inhibiting HSP90 and chaperone-mediated autophagy;The Korean Journal of Physiology & Pharmacology;2024-07-01

2. Estrogen Signals through ERβ in Breast Cancer; What We Have Learned since the Discovery of the Receptor;Receptors;2024-05-03

3. Protecting the Brain: Novel Strategies for Preventing Breast Cancer Brain Metastases through Selective Estrogen Receptor β Agonists and In Vitro Blood–Brain Barrier Models;International Journal of Molecular Sciences;2024-03-16

4. Current progress and prospects for G protein-coupled estrogen receptor in triple-negative breast cancer;Frontiers in Cell and Developmental Biology;2024-02-27

5. Divergent features of ERβ isoforms in triple negative breast cancer: progress and implications for further research;Frontiers in Cell and Developmental Biology;2023-10-23